This system could successively deliver both DOX and RA-V into lysosome and mitochondria of cancer cells, and achieved a spatiotemporally controlled release of them to monitor cytochrome c release and apoptotic process, leading to enhanced therapeutic outcomes in MDR tumors [462]. This evidence concerns the gene CYCS and cancer.